discovered that obesity impacts oocyte quality in GnRH agonist long protocols, while BMI does not affect oocyte number and maturity in HMG+CC protocols, suggesting that mild ovarian stimulation may be more suitable for women with obesity (33). This evidence concerns the gene GNRH1 and obesity due to melanocortin 4 receptor deficiency.